Cost-effectiveness thresholds in the USA: are they coming? Are they already here?

被引：55
|
作者：
Dubois, Robert W. [1 ]
机构：
[1] Natl Pharmaceut Council, Washington, DC 20006 USA
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2016年 / 5卷 / 01期
关键词：
QALYS;
D O I：
10.2217/cer.15.50
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [31] Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA
    Kang, Dong-Won
    Lynn, Patricio B.
    Wang, Li
    Zhou, Shouhao
    Shen, Chan
    [J]. PHARMACOECONOMICS-OPEN, 2024,
  • [32] Inappropriate Use of Cost-effectiveness Thresholds as Intervention Thresholds - Potential for Overtreatment of Low Risk Individuals
    Mccloskey, Eugene
    Johansson, Helena
    Harvey, Nicholas
    Compston, Juliet
    Cooper, Cyrus
    Kanis, John
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 108 - 108
  • [33] Cost-effectiveness issues in type 2 diabetes prevention in the USA
    Palmer, AJ
    Roze, S
    [J]. DIABETES, 2002, 51 : A279 - A279
  • [34] Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use
    Culyer, Anthony J.
    [J]. HEALTH ECONOMICS POLICY AND LAW, 2016, 11 (04) : 415 - 432
  • [35] Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
    Espinosa, Oscar
    Rodriguez-Lesmes, Paul
    Romano, Giancarlo
    Orozco, Esteban
    Basto, Sergio
    Avila, Diego
    Mesa, Lorena
    Enriquez, Hernan
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024,
  • [36] The estimation of cost-effectiveness thresholds prior to the start of large clinical studies
    Van Staa, T. P.
    Cooper, C.
    Leufkens, H. G.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A382 - A382
  • [37] INVESTMENT AND DISINVESTMENT OF HEALTH TECHNOLOGIES: THE NEED FOR TWO COST-EFFECTIVENESS THRESHOLDS
    Paulden, M.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A33 - A33
  • [38] Cost-effectiveness thresholds or decision-making threshold: a novel perspective
    Lihua Sun
    Xiaochen Peng
    Shiqi Li
    Zhe Huang
    [J]. Cost Effectiveness and Resource Allocation, 21
  • [39] Cost-effectiveness Thresholds Used by Study Authors, 1990-2021
    Neumann, Peter J.
    Kim, David D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (15): : 1312 - 1314
  • [40] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Andréa Marques
    Óscar Lourenço
    Gustaf Ortsäter
    Fredrik Borgström
    John A. Kanis
    José António P. da Silva
    [J]. Calcified Tissue International, 2016, 99 : 131 - 141
12345